Skip to main content

Table 1 Characteristics of study patients at the time of diagnosis of hepatocellular carcinoma by hepatitis B presentation group

From: Late presentation of hepatitis B among patients with newly diagnosed hepatocellular carcinoma: a national cohort study

  Type of presentation p-value
Late presentation
N (%)
Irregular visits
N (%)
Regular visits
N (%)
Number of patients 413 527 336  
Sex     0.15
 Male 343 (83.1) 415 (78.7) 262 (78.0)  
 Female 70 (17.0) 112 (21.3) 74 (22.0)  
Age (years)     0.15
  ≥ 40 – <  50 105 (25.4) 106 (20.1) 64 (19.0)  
  ≥ 50 – <  60 165 (40.9) 230 (43.6) 163 (48.5)  
  ≥ 60 143 (34.6) 191 (36.2) 109 (32.4)  
Income percentile     < 0.001
  ≤ 30th 107 (25.9) 155 (29.4) 62 (18.5)  
  > 30th – ≤ 70th 155 (37.5) 196 (37.2) 113 (33.6)  
  > 70th 151 (36.6) 176 (33.4) 161 (47.9)  
Initial treatment     < 0.001
 Liver transplantation 0 (0) 1 (0.2) 1 (0.3)  
 Resection 40 (6.7) 59 (11.2) 60 (17.9)  
 RFA 3 (0.7) 23 (4.4) 28 (8.3)  
 TACE 193 (46.7) 219 (41.6) 140 (41.7)  
 Other 95 (23.1) 116 (22.0) 50 (14.9)  
 No treatment 82 (19.9) 109 (20.7) 57 (17.0)  
Residential area     0.12
 Metropolitan 248 (60.1) 328 (62.2) 226 (67.3)  
 Rural 165 (39.9) 199 (37.8) 110 (32.7)  
  1. RFA radiofrequency ablation, TACE transarterial chemoembolization.Income percentile is based on household income